ClinicalTrialsFinder

Refractory Primary Mediastinal Large B-Cell Lymphoma Clinical Trials in Dijon

1 recruitingDijon, France

Showing 1–1 of 1 trials

Recruiting
Phase 2

Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse

Refractory High Grade B-Cell LymphomaRefractory Transformed B-cell Non-Hodgkin LymphomaDiffuse Large B Cell Lymphoma Refractory+1 more
The Lymphoma Academic Research Organisation65 enrolled13 locationsNCT06271057